Closing will not save your customization unless you have added the item to your shopping cart or favorites.
Click OK to close the MILLIPLEX® MAP tool or Cancel to return to your selections.
Design and price your MILLIPLEX® MAP kits.
Our broad portfolio consists of multiplex panels that allow you to choose, within the panel, analytes that best meet your needs. On a separate tab you can choose the premixed cytokine format or a single plex kit.
Choose fixed kits that allow you to explore entire pathways or processes. Or design your own kits by choosing single plex MAPmates™, following the provided guidelines.
The following MAPmates™ should not be plexed together:
-MAPmates™ that require a different assay buffer
-Phospho-specific and total MAPmate™ pairs, e.g. total GSK3β and GSK3β (Ser 9)
-PanTyr and site-specific MAPmates™, e.g. Phospho-EGF Receptor and phospho-STAT1 (Tyr701)
-More than 1 phospho-MAPmate™ for a single target (Akt, STAT3)
-GAPDH and β-Tubulin cannot be plexed with kits or MAPmates™ containing panTyr
.
| Catalogue Number | Ordering Description | Qty/Pack | List |
To begin designing your MILLIPLEX® MAP kit select a species, a panel type or kit of interest.
| Species |
Panel Type |
Selected Kit |
Sample Type |
Edit |
| Select A Species | . |
| Select A Panel Type | . |
| Select A Kit | . |
| Select A Sample Type | For some panels, sample type will determine which analytes can be plexed together. |
Design your own kit or select from our premixed and single plex panels.
Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
| Catalogue Number | Ordering Description | Qty/Pack | List |
| Species |
|
| Panel Type | |
| Selected Kit | |
| Qty | Catalogue Number | Ordering Description | Qty/Pack | List Price |
| 96-Well Plate |
| Qty | Catalogue Number | Ordering Description | Qty/Pack | List Price |
| Qty | Catalogue Number | Ordering Description | Qty/Pack | List Price |
| 48-602MAG | Buffer Detection Kit for Magnetic Beads | 1 Kit |
Customers purchasing multiple kits may choose to save storage space by eliminating the kit packaging and receiving their multiplex assay components in plastic bags for more compact storage.
The Product Has Been Added To Your Cart
You can now customize another kit, choose a premixed kit, check out or close the ordering tool.
- Home
- Biopharmaceutical Manufacturing
- Gene Therapy Manufacturing
Products – Testing – Manufacturing
Learn
Gene therapy best practices, application and process information
Webinars
- Sf-RVN Cell Line & CD Media Platform: A Production Platform for VLP and AAV
- An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Readiness
- Is Phase-Appropriate Validation the Right Choice for your Cell or Gene Therapy?
- Process development guidance for AAV and lentivirus manufacturing based on cost modeling
- Downstream Process Intensification for Virus Purification Using Membrane Chromatography
- Process Development for Cell Therapy and Viral Gene Therapy
- Biosafety of Novel Viral Therapies
- Promises and Challenges of Manufacturing and Testing Viral Producer Cell Lines
- Latest Updates in Biosafety Testing for Gene Therapy
- Viral Safety for Novel Biological Therapies
- Challenges in Viral and Gene Therapy Product Testing
Videos
|
Selecting The Right CMO
|
Reducing The Risk of Gene Therapy
|
|
|
Cost Modeling
|
Process Development Mistakes
|
|
|
Assuring Viral Safety
|
Intensified Virus Purification
|
|
|
Efficient DNA Clearance
|
||
Articles
- Updated US FDA Guidance for the Gene Therapy Industry: Key Changes and Areas of Increased Focus
- Cell and Gene Therapy Definitions for Raw Materials, Starting Materials, Drug Substance and Drug Product
- Avoiding Costly And Time-Consuming Mistakes In Gene Therapy Process Development
- Accelerating The Time To Market Of Gene Therapies Through Use Of A Platform Approach To Characterization And Safety Testing
- Downstream Process Intensification Of Virus Purification Using Single-Use Membrane Chromatography
- Rapid Sterility Testing: Viral And Gene Therapy Applications
Collateral
- Optimization, Validation and Implementation of Retroviral Retentive Filters for Production of Adeno-Associated Virus (AAV)
- Process Development and Scale-Up for Transient Transfection-Based Lentivirus Production in Suspension White Paper
- Reducing the Risk During Cell and Gene Therapy Development and Manufacturing White Paper
- Considerations for Development of a Platform Lentivirus Harvest Clarification Process for Cell and Gene Therapy Application Note
- Risk Mitigation Strategies for Raw and Starting Materials used in Gene Therapies White Paper
- Partnering Together for Faster Vector Production and Testing
- Gene Therapies: Overcoming the biggest hurdles in manufacturing